Cytologic features of the bulbar conjunctiva in patients with primary open-angle glaucoma-associated dry eye disease

Authors

DOI:

https://doi.org/10.31288/oftalmolzh2023438

Keywords:

glaucoma, dry eye disease, impression cytology, bulbar conjunctiva, hypotensive eye drops, preservatives

Abstract

Purpose: To examine the features of the bulbar conjunctiva in patients who developed dry-eye disease (DED) after drug treatment for primary open-angle glaucoma (POAG).

Methods: Impression cytology was performed by applying twice a strip of cellulose acetate filter to the ocular surface to remove the superficial epithelial layers of the temporal bulbar conjunctiva. The strips were removed with a peeling motion in a few seconds, and the samples were immediately fixed in 95% ethyl alcohol, stained with hematoxylin and eosin, mounted on glass slides and coverslipped for light microscopy. Squamous metaplasia was graded according to Nelson’s grading system on the basis of cell morphology, staining and integrity as well as the nucleus-to-cytoplasm ratio. This study included a case group of 80 patients (mean age, 63.8 ± 6.7 years) with POAG-associated DED, with the group being divided into four subgroups. Subgroups 1 and 2 were composed of 40 patients each, with glaucoma duration of less or more than 5 years, respectively. Subgroups a and b were composed of 40 patients each, with a number of topical ocular hypotensive drugs used equal to one or at least two, respectively. The control group was composed of 20 apparently healthy volunteers (mean age, 67.9 ± 8.9 years). All patients underwent a routine eye examination.

Results:  All patients with glaucoma had symptoms of DED with Ocular Surface Disease Index (OSDI) scores of at least 15. In subgroup 1, 60% had Nelson’s grade 1 and 40%, Nelson’s grade 2 squamous metaplasia. In subgroup 2, 10% had Nelson’s grade 1; 60%, Nelson’s grade 2 and 30%, Nelson’s grade 3 squamous metaplasia. In subgroup a, 20% had Nelson’s grade 1; 60%, Nelson’s grade 2 and 30%, Nelson’s grade 3 squamous metaplasia. In subgroup b, 10% had Nelson’s grade 1; 60%, Nelson’s grade 2 and 30%, Nelson’s grade 3 squamous metaplasia.

Conclusion: Changes in the bulbar conjunctival epithelium corresponded to Nelson’s grade 2 or 3 squamous metaplasia in 80% of patients who developed DED after drug treatment for POAG. The severity of squamous metaplasia correlated with the duration of glaucoma and, consequently, longer use of hypotensive eye drops (r1 = 0.15, p1 = 0.02, p2 = 0.01). Findings of the current study and international guidelines argue for the use of the medications containing no preservatives or potentially toxic components in long-term therapy against glaucoma.

References

Actis AG, Rolle T. Ocular surface alterations and topical antiglaucomatous therapy: a review. Open Ophthalmol J. 2014 Oct 3;8:67-72. https://doi.org/10.2174/1874364101408010067

Gedde SJ, Vinod K, Wright MM, et al. Primary open-angle glaucoma preferred practice pattern. Ophthalmology. 2020;128:71-150. https://doi.org/10.1016/j.ophtha.2020.10.022

Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res. 2002 Nov;21(6):555-76. doi: 10.1016/s1350-9462(02)00038-1. https://doi.org/10.1016/S1350-9462(02)00038-1

Gipson IK. The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4390; 4391-8. https://doi.org/10.1167/iovs.07-0770

Holló G, Katsanos A, Boboridis KG, Irkec M, Konstas AGP. Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. Drugs. 2018 Jan;78(1):39-64. https://doi.org/10.1007/s40265-017-0843-9

Pérez-Bartolomé F, Martínez-de-la-Casa JM, Arriola-Villalobos P, Fernández-Pérez C, Polo V, García-Feijoó J. Ocular Surface Disease in Patients under Topical Treatment for Glaucoma. Eur J Ophthalmol. 2017 Nov 8;27(6):694-704. https://doi.org/10.5301/ejo.5000977

De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G, Baudouin C. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci. 1999 Mar;40(3):619-30.

Zhang X, Vadoothker S, Munir WM, Saeedi O. Ocular Surface Disease and Glaucoma Medications: A Clinical Approach. Eye Contact Lens. 2019 Jan;45(1):11-18. https://doi.org/10.1097/ICL.0000000000000544

Ciancaglini M, Carpineto P, Agnifili L, Nubile M, Fasanella V, Mastropasqua L. Conjunctival modifications in ocular hypertension and primary open angle glaucoma: an in vivo confocal microscopy study. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3042-8. https://doi.org/10.1167/iovs.07-1201

The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007 Apr;5(2):93-107. https://doi.org/10.1016/S1542-0124(12)70082-4

Bulat N, Cuşnir VV, Procopciuc V, Cușnir V, Cuşnir NV. Diagnosing the Dry Eye Syndrome in modern society and among patients with glaucoma: a prospective study. Rom J Ophthalmol. 2020 Jan-Mar;64(1):35-42. https://doi.org/10.22336/rjo.2020.8

Singh R, Joseph A, Umapathy T, Tint NL, Dua HS. Impression cytology of the ocular surface. Br J Ophthalmol. 2005 Dec;89(12):1655-9. https://doi.org/10.1136/bjo.2005.073916

Calonge M, Diebold Y, Sáez V, Enríquez de Salamanca A, García-Vázquez C, Corrales RM, Herreras JM. Impression cytology of the ocular surface: a review. Exp Eye Res. 2004 Mar;78(3):457-72. https://doi.org/10.1016/j.exer.2003.09.009

Nelson JD, Wright JC. Conjunctival Goblet Cell Densities in Ocular Surface Disease. Arch Ophthalmol. 1984;102(7):1049-1051. https://doi.org/10.1001/archopht.1984.01040030851031

Zhmud T, Drozhzhyna G, Malachkova N. Evaluation and comparison of subjective and objective anterior ocular surface damage in patients with type 2 diabetes mellitus and dry eye disease. Graefes Arch Clin Exp Ophthalmol. 2023 Feb;261(2):447-452. Epub 2022 Aug 27. https://doi.org/10.1007/s00417-022-05806-3

Citirik M, Berker N, Haksever H, Elgin U, Ustun H. Conjunctival impression cytology in non-proliferative and proliferative diabetic retinopathy. Int J Ophthalmol. 2014 Apr 18;7(2):321-5. doi: 10.3980/j.issn.2222-3959.2014.02.23.

The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007 Apr;5(2):75-92. https://doi.org/10.1016/S1542-0124(12)70081-2

Winebrake JP, Drinkwater OJ, Brissette AR, et al. The TFOS Dry Eye Workshop II: Key Updates. Ophthalmic Pearls. CORNEA. 2017. https://doi.org/10.12968/opti.2017.9.6767

Zhmud TM, Malachkova NV, Drozhzhyna GI. [A method for performing conjunctival impression cytology in dry eye associated with type 2 diabetes]. Certificate No. 111941 issued on February 21, 2022.

Richhariya A, Sahai A, Shamshad MA, Kumar PR, Ansari M. Effects Of Long-Term Use of Topical Antiglaucoma Drugs on Ocular Surface: A Cross Sectional Study. Delhi J Ophthalmol. 2022;32:45-9. https://doi.org/10.7869/djo.740

Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM. Inflammation in Glaucoma: From the back to the front of the eye, and beyond. Prog Retin Eye Res. 2021 Jul;83:100916. Epub 2020 Oct 17. https://doi.org/10.1016/j.preteyeres.2020.100916

Yang Y, Huang C, Lin X, Wu Y, Ouyang W, Tang L, et al. 0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice. Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3375-3384. https://doi.org/10.1167/iovs.18-24013

Published

2023-09-04

How to Cite

1.
Zhmud TM, Tetarchuk V, Andrushkova OO, Demchuk AV, Hrizhymalska KY, Veretelnyk SP. Cytologic features of the bulbar conjunctiva in patients with primary open-angle glaucoma-associated dry eye disease. J.ophthalmol. (Ukraine) [Internet]. 2023 Sep. 4 [cited 2024 Nov. 6];(4):3-8. Available from: https://ua.ozhurnal.com/index.php/files/article/view/37

Issue

Section

Clinical Ophthalmology